Trial
NCT01801046
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
mitoxantrone hydrochloride
Why stopped
Insufficient Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-30